RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of RGBP
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Regen Biopharma Inc stock price ended at $0.750 on Thursday, after gaining 1.35%.
(Updated on Mar 28, 2024)

Sell candidate since Mar 07, 2024 Loss -4.71% PDF

The Regen Biopharma Inc stock price gained 1.35% on the last trading day (Thursday, 28th Mar 2024), rising from $0.740 to $0.750. During the last trading day the stock fluctuated 8.77% from a day low at $0.690 to a day high of $0.750. The price has been going up and down for this period, and there has been a -2.6% loss for the last 2 weeks. Volume fell on the last day by -43 thousand shares and in total, 11 thousand shares were bought and sold for approximately $8.31 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -7.00% during the next 3 months and, with a 90% probability hold a price between $0.529 and $0.93 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

RGBP Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Regen Biopharma Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.754 and $0.82. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, January 25, 2024, and so far it has fallen -28.57%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Regen Biopharma Inc stock

Regen Biopharma Inc finds support from accumulated volume at $0.740 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0605 between high and low, or 8.77%. For the last week the stock has had daily average volatility of 15.54%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RGBP) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Regen Biopharma Inc to open at $0.730, and during the day (based on 14 day Average True Range), to move between $0.643 and $0.86, which gives a possible trading interval of +/-$0.107 (+/-14.24%) up or down from last closing price. If Regen Biopharma Inc takes out the full calculated possible swing range there will be an estimated 28.48% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.750 (0.03%) than the support at $0.740 (1.33%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Regen Biopharma Inc stock A Buy?

Regen Biopharma Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.669 Sell Candidate Unchanged

Predicted Opening Price for Regen Biopharma Inc of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$0.730 ( 2.69%) $0.750

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for RGBP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.790 5.38 %
R2 0.767 2.30 %
R1 0.753 0.393 %
Current price: 0.750
Support S1 0.707 -5.77 %
S2 0.692 -7.67 %
S3 0.669 -10.76 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.83 11.20 %
R2 0.760 1.33 %
R1 0.750 0.0267 %
Current price 0.750
Support S1 0.740 -1.33%
S2 0.710 -5.33%
S3 0.690 -8.00%

FAQ

What is the symbol for Regen Biopharma Inc Stock and on which exchange is it traded?
The symbol for Regen Biopharma Inc is RGBP and it is traded on the OTCBB (OTC Bulletin Board).

Should I buy or sell Regen Biopharma Inc Stock?
Regen Biopharma Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Regen Biopharma Inc Stock?
Regen Biopharma Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Regen Biopharma Inc Stock.

What's the current price of Regen Biopharma Inc Stock?
As of the end of day on the 2024-03-28, the price of an Regen Biopharma Inc (RGBP) share was $0.750.

What is the 52-week high and low for Regen Biopharma Inc Stock?
The 52-week high for Regen Biopharma Inc Stock is $2.62 and the 52-week low is $0.0019.

What is the market capitalization of Regen Biopharma Inc Stock?
As of the 2024-03-28, the market capitalization of Regen Biopharma Inc is 2.813M.

When is the next earnings date for Regen Biopharma Inc?
The upcoming earnings date for Regen Biopharma Inc is Apr 15, 2024.
Click to get the best stock tips daily for free!

About Regen Biopharma Inc

Regen Biopharma Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in actively identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is in the early stages of development of its products, and therapies. Regen BioPharma, Inc. was incorporated in 2012 and is based in La ... RGBP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT